Neostigmine, but not metoclopramide, abolishes ethosuximide-induced functional gastrointestinal disturbances

Pharmacology

Volumn 75, Issue 4, 2005, Pages 187-194

  Sirakov, V ^a   Krastev, A ^a   Kostadinova, I ^a   Turiiski, V ^a  

^a MEDICAL UNIVERSITY OF PLOVDIV   (Bulgaria)

Author keywords

Ethosuximide; Gastrointestinal tract; Metoclopramide; Neostigmine methylsulfate

Indexed keywords

ETHOSUXIMIDE; METOCLOPRAMIDE; NEOSTIGMINE METHYL SULFATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM TRANSPORT; CONTROLLED STUDY; GASTROINTESTINAL SYMPTOM; GASTROINTESTINAL TRACT FUNCTION; HYPERPOLARIZATION; INTESTINE CONTRACTION; MALE; MUSCLE HYPOTONIA; NONHUMAN; PERISTALSIS; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE; STATISTICAL SIGNIFICANCE; STOMACH MUSCLE; X RAY;

ANIMALS; ANTICONVULSANTS; CHOLINESTERASE INHIBITORS; DOPAMINE ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; ETHOSUXIMIDE; GASTROINTESTINAL MOTILITY; GASTROINTESTINAL TRACT; INTESTINES; MALE; MEMBRANE POTENTIALS; METOCLOPRAMIDE; MUSCLE CONTRACTION; MUSCLE, SMOOTH; NEOSTIGMINE; RATS; RATS, WISTAR; STOMACH; TIME FACTORS;

EID: 31544450283     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000088790     Document Type: Article

References (21)

1. Siren A, Eriksson K, Jalava H, Kilpinen-Loisa P, Koivikko M: Idiopathic generalised epilepsies with 3 Hz and faster spike wave discharges: a population-based study with evaluation and long-term follow-up in 71 patients. Epileptic Disord 2002;4:209-216.
2. Guerrini R, Sanchez-Carpintero R, Deonna T, Santucci M, Bhatia KP, Moreno T, Parmeggiani L, Bernardina BD: Early-onset absence epilepsy and paroxysmal dyskinesia. Epilepsia 2002;43:1224-1229.
3. Caraballo RH, Astorino F, Cersosimo R, Soprano AM, Fejerman N: Atypical evolution in childhood epilepsy with occipital paroxysms (Panayiotopoulos type). Epileptic Disord 2001;3:157-162.
4. McAuley JW, Anderson GD: Treatment of epilepsy in women of reproductive age: pharmacokinetic considerations. Clin Pharmacokinet 2002;41:559-579.
5. Kostyuk PG, Molokanova EA, Pronchuk NF, Savchenko AN, Verkluratsky AN: Different action of ethosuximide on low- and high-threshold calcium current in rat sensory neurons. Neuroscience 1992;51:755-758.
6. Tsakiridou E, Bertollini L, de Curtis M, Avanzini G, Pape HC: Selective increase in T-type calcium conductance of reticular thalamic neurons in rat model of absence epilepsy. J Neurosci 1995;15:3110-3117.
7. Lerescke N, Parri HR, Erdemli GG, Guyon A, Turner JP, Willians SR, Asprodini E, Crunelli V: On the action of the anti-absence drug ethosuximide in rat and cat thalamus. J Neurosci 1998;8:4842-4853.
8. Erdemli G, Crunelli V: Ethosuximide decreases Ca2+ activated K+ currents in rat thalamocortical neurons in vitro. J Physiol (Lond) 1997:501-525.
9. Zagorchev P, Sirakov V, Uchikov A, Sirakov N: Ethosuximide inducted changes in the gastro-intestinal tract. Folia Med (Plovdiv) 1998;40(suppl 3B):28-33.
10. Dooley JM, Camfield PR, Camfield CS, Fraser AD: Once-daily ethosuximide in the treatment of absence epilepsy. Pediatr Neurol 1990;6:38-39.
11. Pasricha PJ: Prokinetic agents, antiemetics and agents used in irritable bowel syndrome; in Hardman JG, Limbird LE, Gilman AG (eds): The Pharmacological Basis of Therapeutics, ed 10. New York, Goodman & Gilman/McGraw-Hill Medical, 2001, pp 1021-1026.
12. Fasolato C, Innocenti B, Pozzan T: Receptor-activated Ca2+ influx: how many mechanisms for how many channels? Trends Pharmacol Sci 1994;15:77-83.
13. Macek MJ, Harvey RA, Champe PC: Cholinergic receptors; in Harvey RA, Champe PC (eds): Pharmacology, ed 2. Philadelphia, Lippincott-Raven, 1997, pp 38-39.
14. Bollan B: Calcium-contraction coupling in mouse urogenital smooth muscles; PhD thesis, Université Catholique de Louvain, pp 14-15.
15. Jooste CA, Mustoe J, Collee G: Metoclopramide improves gastric motility in critically patients. Intensive Care Med 1999;25:464-468.
16. Karavias DD, Tepetes K, Vagenas K, Panagopoulos K, Agelopoulou H, Androulakis J, Androulakis J: Gastrografin administration in the treatment of postoperative delayed gastric emptying. Int J Clin Pract 2002;56:173-174.
17. Lee HT, Lee YJ, Chung SJ, Shim CK: Effect of prokinetic agents, cisapride and metoclopramide, on the bioavailability in humans and intestinal permeability in rats of ranitidine, and intestinal charcoal transit in rats. Res Commun Mol Pathol Pharmacol 2000;108:311-323.
18. Stanciu GO: Gastroparesis and its management. Rev Med Chir Soc Med Nat Iasi 2001;105:451-456.
19. Matsuda H, Li Y, Yoshikawa M: Possible involvement of 5-HT and 5-HT2 receptors in acceleration of gastrointestinal transit by escin Ib in mice. Life Sci 2000;66:2233-2238.
20. Wallenborn J, Rudolph C, Gelbrich G, Goerlich TM, Dohnert J, Dorner J, Olthoff D: Metoclopramide and dexamethasone in prevention of postoperative nausea and vomiting after inhalational anaesthesia (in German). Anasthesiol Intensivmed Notfallmed Schmerzther 2003;38:695-704.
21. Takeuchi Y, Ikeda T, Takeuchi S, Ito H, Sugiyama Y, Matsukawa T, Iwase S, Mano T: Effect of metoclopramide on muscle sympathetic nerve activity in humans. Environ Med 1993;37:95-98.